About

 

Board members

Povl-Andre Bendz

Chairman

Povl-Andre Bendz (1962) is a partner and CEO of Upfront Chromatography A/S. Povl-Andre has an M.Sc. from Copenhagen Business School and long experience from commercial and financial assignments. Povl-Andre has previously been Vice President and CFO at the Danish company Delta Technology for nine years and has long experience of board work. Povl-Andre has been the chairman of 2cureX AB since 2017 and 2cureX A/S since 2014. Povl-Andre is independent against both company and major owners.

2cureX share ownership
51 282 shares via own company
Other board assignments
Agilco Aps
Upfront Chromatography A/S
UpLix P/S

Jørgen Drejer

Board member

Jørgen Drejer (1955) is the CEO and principal owner of the listed company Saniona AB. Jørgen is an experienced entrepreneur and has previously founded a large number of biotech companies, including NsGene and Sophion Biosciences. Jørgen is a member of the Danish Academy of Engineering Sciences and has also been a director of the Danish Research Council for Independent Research. Jørgen holds a doctorate in neurobiology from Copenhagen University and is the author of more than 75 scientific articles. Jørgen has been a board member of 2cureX AB since 2017 and 2cureX A/S since 2017. Jørgen is independent against both company and major owners.

2cureX share ownership
12 820 shares
Other board assignments
Azign Bioscience A/S
Saniona AB
Ellegaard Göttingen Minipigs A/S

Juan Farré

Board member

Juan Farré (1965) is CTO in the Danish company FORCE Technology. Juan has extensive experience in business development in technology companies. Juan has mannaged several global sales organizatrions. Juan has lived in four countries, worked in more than 40 countries and speaks 8 languages. Juan holds a doctorate in engineering. Juan has been a board member of 2cureX AB since 2017 and 2cureX A/S since 2017. Juan is independent against the company but dependent against major owners.

2cureX share ownership
0 shares
Other board assignments
Delta Care A/S
Delta New-Bizz A/S
Delta Reader A/S
Force Certification A/S
Force Technology Asia Holding A/S
Ictalcare A/S
Syddansk Innovation A/S

Simon Hesse Hoffmann

Board member

Simon Hesse Hoffmann (1978) has extensive experience in finance, which includes financial strategy, liquidity management, risk management and cash flow control. Simon is a board member in WireOnAir A/S, a company specializing in wireless technology in soft and hardware. Simon holds an MSc in Finance and International Business from Copenhagen Business School. Simon has been a board member of 2cureX AB since 2017 and 2cureX A/S since 2017. Simon is independent against both company and major owners.

2cureX share ownership
0 shares
Other board assignments
JHO Holding ApS
WireOnAir A/S

Timm Jessen

Board member

Timm Jessen (1962) is a co-founder of 2cureX and has been a board member of 2cureX since 2006. Timm is co-founder and CEO of Topas Therapeutics. Timm started his commercial career in Hoechst AG, where he was a member of the company's management and strategy team. Timm has also served as CSO and COO for EcotecOAI, where he played an important role in the company's strategic decision to initiate drug development programs. Timm is independent against both company and major owners.

2cureX share ownership
583 902 shares
Other board assignments
Topas Theraoeutics GmbH

Ulrich Spengler

Board member

Ulrich Spengler (1967) is the founder of Altona Diagnostics GmbH and has extensive experience in in vitro diagnostics, product and company development. Prior to the establishment of Altona Diagnostics GmbH, Ulrich founded the diagnostic company Artus GmbH, which was acquired by Qiagen in 2005. Ulrich is a board member of 2cureX AB since 2017 and 2cureX A/S since 2013. Ulrich is dependent against both company and major owners.

2cureX share ownership
1 099 296 shares via partly owned company
Other board assignments
Altona Diagnostics GmbH
LISCO Beteiligungs- und Beratungsgesellschaft mbH

Ole Thastrup

Board member

Ole Thastrup (1953) is co-founder and CEO of 2cureX. He has been a board member of 2cureX since 2006. Ole is also Professor at the University of Copenhagen. Prior to 2cureX Ole was Head of Carlsberg Biosector where he was responsible for Carlsberg's biomedical research. Before that, Ole was the scientific founder and Chief Scientific Officer of BioImage A/S (now Thermo Fischer BioImage) that was spun out of Novo Nordisk A/S. Ole is dependent against the company but independent against major owners.

2cureX share ownership
3 778 304 shares via own company
Other board assignments
OT311 ApS

Contact information

Laboratory: 2cureX, Building 8, 2. Tværvej, Bispebjerg Bakke 23, 2400 Copenhagen NV, Denmark| Phone: +45 2211 5399| E-mail: info@2curex.com